Renal 911: Stem Cell Therapy for Urinary Tract Disease
Review the current evidence supporting stem cell therapy and its potential applications in the management of renal and urinary tract disease.
About the Course
This lecture reviews the normal immune environment of the kidney and bladder, explains how inflammatory and reparative pathways become maladaptive, and explores the proposed mechanisms of mesenchymal stromal cell (MSC) therapy, including immunomodulation, cytoprotection, anti-fibrotic signaling, and vascular support. Evidence from experimental models and veterinary clinical studies will be reviewed, with particular attention to feline chronic kidney disease.
This program has been RACE approved (20-1417171) for 1 hour of continuing education credit for veterinarians and veterinary technicians/technologists in jurisdictions that recognize RACE approval.
Learning objectives
- Describe the cellular and immunological processes that drive inflammation, epithelial injury, and fibrosis in renal and lower urinary tract disease.
- Explain the principal proposed mechanisms of MSC action in kidney and bladder disorders, including immunomodulation, paracrine signaling, cytoprotection, and tissue remodeling.
- Compare MSC sources and administration routes and identify how delivery influences biodistribution, feasibility, and safety.
- Discuss the biological rationale of MSC therapy for renal and urinary tract diseases
- Review preclinical and veterinary clinical evidence for MSC therapy in renal and urinary tract diseases
Related reading
Start Learning Now
Explore courses, grow your skills, and earn CE credits - all at your pace.
About the presenter
Rebecca Windsor
Dr. Rebecca Windsor, DVM, DACVIM (Neurology), earned her veterinary degree from the University of California, Davis, in 2005. She completed a small animal medicine and surgery internship at North Carolina State University (2005–2006) and a residency in neurology and neurosurgery at UC Davis (2006–2009), achieving board certification through the American College of Veterinary Internal Medicine in 2009.
Dr. Windsor has extensive experience working in private specialty hospitals in the Washington, D.C. area, the San Francisco Bay Area, and Chicago. Most recently, she served as Chief of the Neurology Department and Neurology Internship Coordinator at Wheat Ridge Animal Hospital in Colorado. In 2024, she was honored as a “Best in Colorado Top Doctor” for excellence in veterinary medicine.
Deeply passionate about clinical research and education, Dr. Windsor has authored numerous publications and has been a Clinician Scientist with Ethos Discovery, a nonprofit scientific incubator, since 2021. She currently leads Ethos Discovery’s neurology research portfolio, focusing on immune-mediated neuroinflammatory diseases, particularly early detection and treatment strategies for necrotizing meningoencephalitis in dogs. In 2024, she was appointed the Ethos Discovery House Officer Research Project Coordinator, and she currently mentors over 100 veterinary interns and residents in clinical research.
In 2025, Dr. Windsor joined Gallant as Director of Veterinary Affairs, where she is dedicated to advancing veterinary medicine and educating the veterinary community on the therapeutic potential of stem cell therapy.
Continue Learning
See allManaging FCGS in Practice: What Every Technician Should Know
Understand the clinical presentation and treatment options for FCGS, including the potential for stem cell therapy for cats with refractory FCGS.
Canine Osteoarthritis: Current Concepts and Advances in Treatment
Review diagnostic and therapeutic approaches and the potential of stem cell therapy for the management of osteoarthritis in dogs.
Uterine-Derived Stem Cells for the Management of Refractory Feline Chronic Gingivostomatitis
Explore current treatment approaches for FCGS and examine clinical trial outcomes using uterine-derived stem cell therapy.